Day: June 7, 2021

QUEBEC, June 07, 2021 (GLOBE NEWSWIRE) — Stelmine Canada (STH-TSXV) (“Stelmine” or the “Company”) has arranged a non-brokered private placement at 0.13 cents per unit, for total gross proceeds of $700,000, to accommodate strong demand from investors following its just-completed private placement at 0.09 cents per unit (refer to June 4, 2021 news release). This new financing will consist of the sale of up to 5,384,615 units of Stelmine (the “Units”) at a price of $0.13 per Unit with each Unit comprising one common share of Stelmine and one half of a share purchase warrant. Each full warrant will entitle the holder to acquire one common share of the Company at $0.20 for a period of 36 months from issuance. The proceeds of the Offering will be used for exploration on the Courcy and Mercator Projects in the Caniapiscau...

Increases Operational Footprint by 50% to Support Strong GrowthGarrett Motion Inc.Photo: Garrett Motion Inc. The expansion area of Garrett’s production facility in Wuhan, China shaded in red.ROLLE, Switzerland, June 07, 2021 (GLOBE NEWSWIRE) — Garrett Motion Inc. (Nasdaq: GTX), a leading differentiated technology provider for the automotive industry, announced today it plans to expand and modernize its existing production facility in Wuhan, China to meet increasing customer demand. Garrett’s Wuhan plant opened in 2013 and currently serves major local and global automakers. The expansion is expected to increase the size of the state-of-the-art facility by approximately 50% and is scheduled for completion in the first quarter of 2022. “Garrett has achieved significant growth in Wuhan since we commenced operations...

TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, is pleased to announce that it has launched a new corporate website and upgraded its website address from www.blockchainfoundry.co to www.blockchainfoundry.com. BCF’s new website better reflects the current state of the Company’s business, including new areas of development such as enterprise products and blockchain protocol research and innovations. In addition, BCF has launched an accelerator program to help entrepreneurs realize their start-up vision in the blockchain space. The Company’s website now includes information and an application process for prospective accelerator partners. “We are excited to launch BCF’s new corporate website,” said Dan Wasyluk, CEO of Blockchain...

Leronlimab to be studied as potential HIV PrEP drug in humans through an early clinical trial VANCOUVER, Washington, June 07, 2021 (GLOBE NEWSWIRE) —  CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the publication in Nature Communications of a study showing leronlimab prevented nonhuman primates from being infected with Simian Human Immunodeficiency virus (SHIV), a monkey-human chimeric form of HIV. The results will inform a future human clinical trial evaluating leronlimab as a potential pre-exposure prophylaxis, or PrEP, therapy to prevent human infection from the virus that causes AIDs. “Antibody-based CCR5 Blockade Protects Macaques from Mucosal...

Digital Ally Contributes $13.5 million of Capital to New Business Unit Lenexa, KS, June 07, 2021 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), which develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and event security, today announced the formation of Digital Ally Healthcare, Inc. (“Digital Healthcare”) to pursue opportunities in the healthcare industry. This business initiative is part of the Company’s strategic plan to diversify its product and service offerings to address larger target markets that have significant growth prospects. Digital Healthcare’s goal is to create recurring sources of revenue, expand its profit margins, achieve sustainable positive cash flow and fuel future growth. On...

ATLANTA, June 07, 2021 (GLOBE NEWSWIRE) — Labor SMART, Inc. (LTNC) (the “Company”), previously announced via Twitter, that the Company would entertain offers to sell its Registered Trademark, ‘Labor Smart’, US Trademark Registration number 4311630 (“Trademark”). This will not change the Company’s ticker symbol LTNC or the Company’s name.  Joe Pavlik, LTNC CEO & Takeover Industries President and Chief Science Officer, said, “After review, our executive team has determined that the Trademark does not fit into the long-term plan. The Company is now focused on its subsidiary, Takeover Industries Inc. and rapidly expanding the NXT LVL Line of functional beverage products.” Pavlik further states, “The Company was offered, and has agreed to accept the offer of $250,000.00 USD for the sale of the Trademark, and we also...

Tax automation solution built exclusively for auto leasing operations KING OF PRUSSIA, Pa., June 07, 2021 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, announced a new integration of its Vertex® Lease Tax O Series® with Alfa Start. Alfa Start, built exclusively for auto leasing operations of all sizes, is the preconfigured edition of the cloud-based Alfa Systems, the market leader in asset finance software worldwide. This extends Vertex’s partnership with Alfa, a best-in-class technology provider that powers some of the world’s biggest names in automotive finance. Managing the tax complexity on lease and rental transactions with confidence is critically important for businesses. The constant changes in rates and rules across jurisdictions, states and products...

TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (Dialco), today announced that Dialco has engaged CROMSOURCE, a full-service Contract Research Organization (“CRO”), for its upcoming DIMI IDE usability clinical trial. CROMSOURCE is a high quality, ISO certified international provider of outsourced clinical trial services that has been a trusted partner to pharmaceutical, medical device, and biotechnology companies for more than 20 years. DIMI is an innovative renal replacement system that is cleared by the FDA to treat patients...